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“To do or not to do — that is the question”. Transvascular needle 
aspiration during EBUS (EBUS-TVNA) with review of the literature
Abstract
Introduction: Large vessels are often encountered during endobronchial ultrasound (EBUS). Safety of traversing the vessels 
weighed against a more invasive procedure can be a dilemma. 
Material and methods: We describe a case series of 8 patients who underwent transvascular needle aspiration during EBUS, 
to access a lesion in the absence of an alternate safe window. A 21 gauge EBUS needle was used to traverse either the main or 
a major branch of the pulmonary artery. 
Results: Malignancy was suspected at ROSE in five cases. Granuloma and necrosis noted in 2 cases were confirmed as tubercu-
losis on culture. Diagnostic yield of EBUS-TVNA was 87.5% (7/8). No complications were noted in the immediate post-operative 
period as well as during 6 months of follow up.
Conclusion: EBUS-TVNA in carefully selected patients is a feasible alternative to more invasive procedures with excellent yield. 
Appropriate intraoperative, perioperative and postoperative monitoring and care must be available in the case of fatal bleeds. 
Key words: EBUS, transvascular, TVNA, transvascular needle aspiration, transvascular biopsy
Adv Respir Med. 2021; 89: 386–391
Introduction
Invasive sampling of the mediastinal lymph 
nodes for lung cancer staging is recommended 
by American Thoracic Society (ATS), European 
Respiratory Society (ERS), and American College 
of Chest Physicians (ACCP) [1]. Minimal invasive 
procedure — endobronchial ultrasound (EBUS) 
[2] — guided needle biopsy is a well proven diag-
nostic tool for both malignant and nonmalignant 
diseases [3].
EBUS has, for the most part, made a greater 
portion of the mediastinum accessible to biopsies, 
especially when combined with EUS-B (transe-
sophageal endobronchial ultrasound). Some sta-
tions in the mediastinum are inaccessible or, ac-
cess to these locations is limited by the presence 
of one of the great vessels. These areas include 
stations 3a, 5 and 6 and elsewhere in the hilum 
when a branch of the pulmonary artery or more 
proximally, azygos, superior vena cava or brachio-
cephalic vessels, may be interposed between the 
airway and the pathology. These were once upon 
a time considered beyond the reaches of EBUS [4] 
because biopsy of these lesions needed traversing 
the great vessels. Life-threatening bleeding with 
EBUS-TBNA resulting probably from accidental 
pulmonary artery puncture have been reported [5, 
6]. Multiple case series have now been published 
confirming relative safety of traversal of the great 
vessels in experienced hands [7–11].
Material and methods
We retrospectively analyzed patients who 
underwent endobronchial ultrasound with trans-
vascular needle aspiration (EBUS-TVNA), during 
a 3-year period from January 2018 to Decem-
ber 2020. Procedural informed consent was 
obtained, and the study being a retrospective 
observation, was approved by the institutional 
ethics committee.
The protocol followed for the patients was 
not any different than for the other cases of 
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EBUS. Images available, including CT chest 
and/or PET-CT, were evaluated preoperative-
ly (Figure 1 and 2). All patients posted for 
EBUS-TBNA at our unit are screened for car-
diopulmonary and other systemic diseases and 
if necessary, further workup is done before the 
procedure. Basic blood work is always reviewed. 
Additionally, planning with the anesthesiology 
team included risks regarding major bleeding. 
Patients were type- and cross- matched. All the 
cases were consulted by experienced interven-
tional pulmonologists. NSAIDs, anticoagulation 
and antiplatelet medications were discontinued. 
All the cases were planned as a day case with 
thoracic surgery backup.
A laryngeal airway was placed for general 
anesthesia and this allowed precision of biopsy 
and limited passes. Careful evaluation of the 
lesion and the vascular structures were done to 
find an appropriate window for biopsy. Every 
Figure 1. Retrocardiac lesion
Figure 2. Fluorodeoxyglucose avid retrocardiac mass lesion
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attempt was made to avoid traversing the vas-
culature. Olympus scope BFUC180F was used 
for all the procedures. Twenty-one-gauge EBUS 
needle was used for the biopsy. Once the site of 
entry was finalized, the needle was advanced 
into the lesion traversing the vessel (Figure 3, 
4). Ventilation was held during the puncture to 
avoid any shearing of the vessel wall. Once the 
needle was in the lesion, the stylet was removed, 
and the needle was moved back and forth 5 times 
with the application of suction. The sample was 
analyzed using rapid onsite evaluation (ROSE). 
Maximum of 3 needle passes were done for 
each of the lesions. After each pass, the airway 
was examined for bleeding and the vessel was 
checked for hematoma. Cold saline and epineph-
rine (1:10000) were used for hemostasis. Fogarty 
balloon catheter and a bronchial blocker was on 
standby for all the procedures.
Results
During the study period 2018–2020, 8 pa-
tients underwent EBUS-TVNA at our institution. 
The lesions were either at regular lymph node 
stations or had one of the vessels obstructing the 
needles direct access to the lesion. 
Eight patients were identified out of which 
six had planned procedures done using general 
anesthesia, while in the other 2 cases, the deci-
sion was taken during the procedure done under 
procedural sedation. A transvascular approach 
was only adopted if a clear window to access the 
lesion for biopsy was absent. 
Three cases involved station 5 where the left 
main pulmonary artery was traversed. Two cases 
needed traversing the common basal trunk of the 
left pulmonary artery. Three other cases needed 
traversing the interlobar pulmonary artery (right) 
for right hila masses. Six out of the eight cases 
were noted on ROSE to be suggestive of malignan-
cy (75%) and confirmed on final diagnosis. ROSE 
identified necrosis in 1 and granuloma in another 
subject, both of which were finally diagnosed as 
tuberculosis. 
Four of the cases developed mild bleeding 
needing cold saline and epinephrine. No major 
bleeding was noted. Three needle passes were 
done to ensure adequacy of material for immu-
nohistochemistry (IHC). 
Discussion
Prior to the advent of EBUS, TBNA typically 
of station no. 7 (subcarinal) was a blind procedure 
done based on pre-procedure CT scans. Blood 
aspiration meant pulmonary artery puncture 
in which case, the needle was withdrawn and 
re-inserted at a different site if the airway was 
clean. EBUS-TBNA has prevented such accidental 
punctures. Fatal bleedings [5] have been reported 
in the literature, but EBUS-TBNA is for the most 
part a safe procedure [12]. Complications of he-
momediastenum, hemothorax and  pneumomedi-
astinum after EBUS-TBNA [6] have been reported. 
Despite these concerns, multiple case series have 
documented relative safety of transvascular nee-
dle aspiration as summarized in Table 2. 
Table 1. Details of the cases who underwent transvascular needle aspiration during EBUS TVNA at Amrita Institute Of 
Medical Sciences, Aims Ponekkara, Kochi, India
Case no. & 
patient details









1. 76/M Mass encasing 
brachiocephalic 
with right hilar mass
26 × 29 Interlobar PA 2 Squamous cell 
carcinoma
Esophageal cancer
2. 74/M LLL mass 23 × 22 LMPA 1 Metastatic nsclca Adenocarcinoma lung
3. 65/M Station 5 lymph node 25 × 30 LMPA 3 Necrotic tissue Tuberculosis
4. 53/F LUL mass 53 × 39 LMPA 3 Adenocarcinoma Adenocarcinoma lung
5. 55/M Right hilar mass 28 × 27 Interlobar PA 3 Granuloma Tuberculosis
6. 64/F LLL mass/lymph node 24 × 17 LMPA 3 Nsclca Adenocarcinoma lung
7. 47/M Right hilar mass 26 × 29 Interlobar PA 3 Suspicious 
for malignancy
Spindle Cell Neuroendocrine 
neoplasm
8. 49/F Left hilar mass encasing 
the great vessels
25 × 28 LMPA 3 Nsclca Adenocarcinoma
Interlobar PA — right main PA; NSCLCa — non small cell lung cancer; PA — pulmonary artery; LMPA — left main pulmonary artery; PA — pulmonary artery
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Suprasternal puncture of the pulmonary 
artery has been recorded in the literature to be 
harmless dating back to the 1950’s when the 
pulmonary arteries were inadvertently entered 
while aiming for the left atrium to do flow studies 
[13]. Physiologically, the pulmonary artery sys-
tem is a low-pressure high-capacitance structure. 
Anatomically, the pulmonary veins have a thin 
wall. The low-pressure system contributes to less 
bleeding with a small-bore needle (21–22 gauge) 
Figure 3. Lesion beyond the right main pulmonary artery with Doppler
Figure 4. Transvascular needle aspiration during endobronchial ultrasound with transvascular needle aspiration. PA — pulmonary artery
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Table 2. Summary of cases series with endobronchial ultrasound with transvascular needle aspiration




Vessel traversed Diagnostic yield [%] Complications
Nuguru et al. [18] 2017 12 MPA/branch 100 None






but 89% of the malignancies 
diagnosed correctly 
1 each of:  respiratory failure, 
atrial fibrillation-related tachy- 
cardia, moderate bleeding 
Rachid MM [19] 
(abstract)
2018 24 MPA/branch 91.66 None
Folch [9] 2016 10 MPA 90 None
Kazakov [8] 2017 33 MPA/branch, aorta 73 None
Panchabhai [11] 2015 10 MPA/branch 90 None
Mehta et al. [12] 2018 10 MPA/intra PA 90 None
Our study 2020 8 MPA/branch 100 None
Boujaoude et al.[10] 2013 2 Branch MPA 100 None
Cetinkaya et al. [20] 2018 4 MPA/branch 100 None
LMPA — main pulmonary artery; PA — pulmonary artery
biopsy, but the thin wall makes the risk of tear 
higher. Longer needle dwell time in the vessel and 
respiratory excursions increase the risk of vessel 
injury. The pulmonary artery is in close proximity 
to a significant portion of the airway and need for 
EBUS-TVNA is not unusual. 
Boujaoude et al. [9] reported safety of punc-
turing the main pulmonary artery in 2013 in 2 cas-
es and since then most of the vessels seen during 
EBUS [7, 14] have been traversed. Intrapulmonary 
artery lesions have also been sampled with good 
yield and safety profile  [11, 15]. 
General anesthesia is used in most of the 
case series except Folch et al. [18] and Kazakov et 
al.  [7]. Just as in our series, they also noted that 
anesthesia did not influence the complications. In 
a large series of 35 patients, Naaman et al. [14] 
(published as an abstract) noted reversible mild to 
moderate complication in only 3 patients, and all 
of them recovered fairly well without any major 
sequalae. Similarly, puncturing other vessels, 
e.g. azygous, SVC and brachiocephalic artery 
did not change the risk [14]. Our study involved 
puncturing the main pulmonary artery at different 
sites, and we did not notice any increased com-
plication rate just as noted by Panchabhai et al. 
[10]. Kazakov et al. [7] in their series traversed 
the aorta as well and did not notice any increase 
in complications.
The average diagnostic yield for the EBUS-TV-
NA in various case series seems to be well over 
80%. We found a diagnosis in 87% in our study, 
though in 2 of the cases, the definitive diagnosis 
was not confirmed immediately but was ultimately 
established as tuberculosis. ROSE had identified 
granuloma and necrosis. As with the other case 
series, overall final diagnosis of malignancy was 
very high in our series as well, i.e., at 75% (6/8).
Findings from our study add to the growing 
literature of safety and excellent diagnostic yield 
of EBUS-TVNA in selective cases. 
Our case series has several limitations. The 
sample size was small, and this was a retrospec-
tive chart review which carries its drawbacks. The 
small number is probably related to the relative 
low frequency of these types of cases seen in 
clinical practice, which was also noted in many 
other series in the literature. Ours was also 
a single-center experience. Being retrospective 
in nature, subtle postoperative complications 
could have been missed. We had an excellent 
diagnostic yield but did not have another pro-
cedure to compare with. Overinterpreting of our 
results, both diagnostic yield and the absence of 
complications, would be unwise and we would 
strongly advice against that. 
The EBUS-TVNA should only be attempt-
ed as a last resort after weighing all options 
and is not a replacement for the more inva-
sive procedure like mediastinoscopy. Adequate 
preoperative, intraoperative and perioperative 
planning, monitoring and taking precautions like 
cardiothoracic surgery on standby, are the keys 
to doing a successful procedure. The opinion 
as mentioned in the various case series is one 
of caution. Preferably, this procedure should be 
attempted in a high-volume center and only by 
skilled interventional pulmonologists. We strong-
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ly recommend choosing the patient carefully and 
always attempting to avoid vessel, even though 
EBUS-TVNA appears to be a relatively safe pro-
cedure. While general anesthesia seems to be the 
common consensus for this high-risk procedure, 
cases done under conscious sedation seem to have 
similar results. But we would still advice taking 
a safer approach to this procedure.
Conclusion
In conclusion, using transvascular approach 
expands the stations and areas in the mediasti-
num amenable to biopsy during EBUS. EBUS- 
-TVNA appears to be a relatively safe procedure 
in skilled hands, but safety precautions with strict 
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